Experiment 1
For humans:
Mean - 0 mg - 3.834 mg
Mean - 5 mg - 8.932 mg
Mean - 10 mg - 61.622 mg
Mean - 15 mg - 657.941 mg
Standard Deviation - 0 mg - 1.523
Standard Deviation - 5 mg - 1.594 mg
Standard Deviation - 10 mg - 30.111 mg
Standard Deviation - 15 mg - 212.943 mg
Standard Error - 0 mg - 0.482 mg
Standard Error - 5 mg - 0.504 mg
Standard Error - 10 mg - 9.522 mg
Standard Error - 15 mg - 67.338 mg
Median - 0 mg - 4.12 mg
Median - 5 mg - 8.98 mg
Median - 10 mg - 72.395 mg
Median - 15 mg - 722.905
Mode - 0 mg - DNE
Mode - 5 mg - DNE
Mode - 10 mg - DNE
Mode - 15 mg - DNE
Experiment 2
For rats:
Mean - 0 mg - 10.516 mg
Mean - 10 mg - 11.112 mg
Standard Deviation - 0 mg - 2.225 mg
Standard Deviation - 10 mg - 7.403 mg
Standard Error - 0 mg - 0.995 mg
Standard Error - 10 mg - 3.311 mg
Median - 0 mg - 9.24 mg
Median - 10 mg - 8.99 mg
Mode - 0 mg - NONE
Mode - 10 mg - NONE
Results
Experiment 1
Experiment 2
Analysis
Experiment 1
For the human experiment we performed an ANOVA test because we had multiple groups. The ANOVA test produced a p-value of 1.4E-16, which is less than .05 so it shows statistical significance between the groups. To follow up with this we performed a Bonferroni Correction, doing t-tests between the individual groups. The results of this were: 0mg vs 5mg = 8.6E-7, 0mg vs 10mg = 9.95E-6, 0mg vs 15mg = 1.39E-8, 5mg vs 10mg = 3.02E-5, 5mg vs 15mg = 1.57E-8, 10mg vs 15mg = 6.48E-08. Taking .05 and dividing by the number of comparisons (6) we get .00833, because all t-test values were less than .00833, we can say there was a statistically significant difference between each group comparison.
Experiment 2
For the rat experiment, we performed a t-test because we only had two groups. The t-test produced a p-value of .867, showing that there was not a statistically significant difference between the 2 groups.
Summary/Discussion
Although we did not get statistically significant results in the rat study, we did get statistically significant results in the human study. There was a significant difference in the Inflammotin levels between each group. This tells us that the LPS treatment did increase inflammotin levels in people. it can be inferred that the Inflammotin levels would keep increasing at an exponential rate until the system reaches the body's capacity for producing the protein. according to the overall ANOVA and tests, we can be certain that the size of dosage has an impact on the levels of inflammotin in humans, but not in rats.